rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TECH
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      StoneX reiterates Hold on Bio-Techne stock as Merck deal nears
      Nov 12Investing.comSNEXTECHMRK
      Merck KGaA raises 2026 outlook as Bio-Techne deal nears completion
      Nov 12Seeking AlphaTECHMRK
      TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances

      Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

      Nov 9The Globe and MailTECH
      Bio-Techne (TECH), What Is Behind The Fresh Attention Now?
      Nov 4Yahoo FinanceTECH
      Bio-Techne earnings missed by $0.03, revenue fell short of estimates
      Nov 4Investing.comTECH
      BIO-TECHNE DECLARES DIVIDEND
      Nov 4Yahoo FinanceTECHMRK
      Bio-Techne faces earnings test ahead of Merck acquisition close
      Nov 2Investing.comTECHMRK
      Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?
      Nov 2Yahoo FinanceTECH
      What You Need to Know Ahead of Bio-Techne’s Earnings Release
      Oct 26BarchartTECH
      Bio-Techne opens GMP small molecule facility in Bristol, UK
      Oct 9Yahoo FinanceTECH
      Insider Activity Update: John L Higgins Executes Options Exercise, Resulting In $751K At Bio-Techne - Bio

      On September 30, it was revealed in an SEC filing that John L Higgins, Director at Bio-Techne (NASDAQ:TECH) executed a significant exercise of company stock options. What Happened: A Form 4 filing with the U.S.

      Oct 1BenzingaTECH
      2 Cash-Producing Stocks Worth Investigating and 1 We Brush Off

      Detailed price information for Lennox International (LII-N) from The Globe and Mail including charting and trades.

      Sep 28The Globe and MailTECH
      Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package

      Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company’s acquisition by Merck KGaA of Darmstadt, Germany. The German group is paying $73 a share in cash, valuing the business at about $11.3 billion including debt. They also voted down the executive compensation proposal attached to the deal, which is an unusual pairing. […]

      Sep 26Yahoo FinanceTECHMRK
      Robert V Baumgartner Exercises Options, Realizes $754K - Bio-Techne (NASDAQ:TECH)

      Robert V Baumgartner, Board Member at Bio-Techne (NASDAQ:TECH), reported a large exercise of company stock options on September 24, according to a new SEC filing. What Happened: In an insider options exercise disclosed

      Sep 25BenzingaTECH
      Is Bio-Techne Stock Outperforming the Nasdaq?

      Bio-Techne has outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects.

      Sep 24Yahoo FinanceTECH
      Merck KGaA (XTRA:MRK) Clears Key Acquisition Hurdle After Shareholder Approval

      Merck KGaA (XTRA:MRK) has received shareholder approval from Bio-Techne investors for its planned acquisition of the US life sciences group. The vote clears a major corporate hurdle in the transaction process, with completion still subject to remaining regulatory reviews. The planned merger is expected to broaden the combined product set and customer reach across multiple stages of the life sciences workflow. The Bio-Techne shareholder approval is important, but it should not be the only...

      Sep 23Yahoo FinanceTECHMRK
      Bio-Techne shareholders approve Merck KGaA acquisition
      Sep 23Investing.comTECH
      Bio-Techne Shareholders Approve Takeover by Merck KGaA
      Sep 23Yahoo FinanceTECH
      Bio-Techne Opens New Customer Experience Center in Germany
      Sep 22Yahoo FinanceTECH
      Bio-Techne opens customer experience center in Düsseldorf
      Sep 22Investing.comTECH
      Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

      Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the opening of its new Customer Experience Center in Düsseldorf, Germany, a flagship facility designed to bring European customers closer to Bio-Techne's latest innovations and scientific expertise.

      Sep 22Yahoo FinanceTECH
      Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound

      Bio-Techne (TECH) has drawn fresh attention after recent trading left the share price at $72.27, with performance over the past month roughly flat and the past 3 months showing a strong double digit gain. Recent trading tells a mixed story for Bio-Techne. The share price return of 29% over the past 90 days sits alongside a 1-year total shareholder return of 41%, while the 5-year total shareholder return shows a decline of 44%. This hints that momentum has only recently improved following a...

      Sep 15Yahoo FinanceTECH
      Bio-Techne issues supplemental merger disclosures amid shareholder lawsuit
      Sep 14Investing.comTECH
      Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?

      Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Sep 11Yahoo FinanceTECH
      Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others

      500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein Market Research Use Recombinant Protein Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Research Use Recombinant Protein Market by Product, Product Formulation, Species, Host Cell, Application, End User, Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. Research Use Recombinant Pro

      Sep 8Yahoo FinanceTECHTMO
      IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players

      500-Page Report Ranks Suppliers by Competitive Position Across the Company Evaluation Matrix as Infectious Disease Testing Drives the Largest Application Segment IVD Raw Material Market IVD Raw Material Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "IVD Raw Material Market by Product Type, Technology, Application, Supply Source, Origin, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. The global in vitro diagnostics (IVD) raw material market is pro

      Sep 8Yahoo FinanceTECHTMO
      Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

      Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substantial reductions in operational emissions during fiscal year 2026.

      Sep 1Yahoo FinanceTECH
      Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks

      Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.

      Aug 31Yahoo FinanceTECH

      This is the newest page. Registered accounts read further back.